ONK Therapeutics and Trinity College Dublin Collaborate in an Enterprise Ireland Funded Project to Optimize Metabolism of NK Cells for Improved Cancer Therapies
Collaboration between ONK Therapeutics and Dr. David Finlay’s group at Trinity College Dublin, Ireland Two-year Enterprise Ireland Innovation Partnership Programme (IPP) project grant of €373,295 Research to explore metabolic reprogramming and engineering of natural killer (NK) cells for improved cancer therapy Galway, Ireland and San Diego, USA, 8 June 2021 – ONK Therapeutics Ltd, an […]